Chemeq

Chemeq founder plans $5m IPO

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

A Bentley biotech company led by Graham Melrose is planning a $5 million initial public offering, after six years of research on the development of synthetic antibiotics.

Chemeq into administration

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

EMBATTLED animal drug manufacturer Chemeq Ltd has been placed in administration and receivership after an appeal to overturn a court ruling ordering the company repay $60 million to its creditors fail

Ferrier Hodgson appointed receivers of Chemeq

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Martin Bruce Jones, Andrew John Saker and Darren Gordon Weaver of Ferrier Hodgson have been appointed as receivers and managers to Rockingham-based Chemeq Ltd, which went into administration on Wednesday.

Chemeq loses case, goes into administration

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Drug manufacturer Chemeq Ltd has been placed in administration after an appeal to overturn a court ruling ordering the company repay $60 million to its creditors failed.

Chemeq loses all of its production staff

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Struggling animal pharmaceutical manufacturer Chemeq has been dealt another blow, with its entire production and maintenance staff walking out on the company following significant uncertainty about the group's financial future.

Supreme Court to consider Chemeq refinancing bid tomorrow

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

The Supreme Court will consider an application by Rockingham-based Chemeq Ltd to permit the implementation of a $75 million refinancing proposal from little-known International Finance Corporation of Australasia Pty Ltd tomorrow.

Chemeq in $75m refinancing deal with mystery banker

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Beleagured Rockingham-based animal pharmaceutical products manufacturer Chemeq Ltd has announced a $75 million refinancing proposal from a little-known St Georges Terrace banker International Finance Corporation of Australasia Pty Ltd.

Chemeq wins injunction against receivers

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Struggling animal pharmaceutical company Chemeq has won a court injunction that will restrain its convertible bondholders from appointing a receiver.

No receivers for Chemeq while appeal planned

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

The vultures are circling, but Rockingham-based animal pharmaceutical products manufacturer Chemeq Ltd has life in it yet, as the Supreme Court yesterday restrained bondholders Stark Trading and Harmony Investment Fund from appointing a receiver.

Chemeq appeals court finding

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

CHEMEQ is appealing a court finding that it must repay $60 million to US bond trader Stark Trading and Harmony Capitol Partners after losing a previous appeal in the Supreme Court.

Chemeq plans last-ditch legal appeal

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

In what is seen as a last-ditch attempt to save the company, Rockingham-based animal pharmaceutical products manufacturer Chemeq Ltd will appeal a court finding that it must repay $60 million to its major financiers.

Chemeq to repay $60m after Supreme Court loss

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Rockingham-based animal pharmaceutical products manufacturer Chemeq Ltd has been ordered to repay $60 million to US bonds trader Stark Trading and Harmony Capital Partners after losing a Supreme Court appeal today.

Chemeq in trading halt ahead of Supreme Court hearing

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Embattled animal pharmaceutical products manufacturer Chemeq Ltd has gone into a trading halt ahead of tomorrow's Supreme Court hearing into the company's application for an injunction against US bonds trader Stark Trading.

Chemeq, Stark dispute adjourned to November 29

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

The dispute between embattled animal pharmaceutical products manufacturer Chemeq Ltd and US bonds trader Stark Trading will be adjourned to November 29 to permit a Supreme Court hearing.

Chemeq takes legal action over bonds

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Embattled Chemeq Ltd has announced that it will shortly be lodging an application with the Supreme Court of Western Australia for a declaration that it has met the revenue covenant set out in the Convertible Bond Deed Poll for the 2006 financial year.

Chemeq plunges as Stark makes $50m bond call

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Chemeq Ltd's share price has plummeted over 33 per cent after convertible bond holder Stark Trading and its associates issued the company with an early redemption notice, seeking repayment of bonds with a face value of $50 million.

Chemeq Ltd - 5/10/2006

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Chemeq and PCAS sign letter of intent to examine Strategic partnership

Chemeq signs letter of intent with European manufacturer

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Animal pharmaceutical products manufacturer Chemeq Ltd has signed a letter of intent with European chemicals manufacturer PCAS SA, which may lead to manufacturing and marketing partnerships.

Chemeq posts $32.6m loss

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Bentley-based animal pharmaceutical company Chemeq Ltd has reported a loss $32.6 million for the year ended 30 June 2006.

Chemeq on the move

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

BENTLEY-BASED animal pharmaceutical company Chemeq Ltd plans to lay off 50 employees and move its headquarters to its Rockingham facility.

Chemeq to lay off 50, move HQ to Rockingham

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Bentley-based animal pharmaceutical company Chemeq Ltd will lay off approximately 50 employees as a part of its new corporate growth strategy.

Newsmaker – Graham Melrose

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

THE founder of animal drug company Chemeq Ltd, Dr Graham Melrose, has retired as a non-executive director. Dr Melrose had been involved with Chemeq since it was founded in 1989.

Melrose retires from Chemeq board

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

After 17 years involvement with the company, former Chemeq chairman Graham Melrose has announced his intention to retire from the board.

Chemeq, ASIC settle

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

BENTLEY biotech company, Chemeq Ltd, has settled its long-running dispute with the Australian Securities and Investments Commission with an agreement to pay a $500,000 fine.

Chemeq to pay $500,000 fine

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

ASIC proceedings against biotech company Chemeq Ltd have been resolved, with the Federal Court today approving the ASIC-suggested penalty of $500,000, payable by Chemeq, in relation to proceedings against the company.

Chemeq makes $4m, satisfies Stark covenant

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Biotech company Chemeq Ltd announced today that it had achieved a gross revenue in excess of $4 million, and possessed over $28 million in cash reserves, satisfying the final milestone covenant in the convertible bond deed poll issued early last year.

Chemeq records $13.6m loss

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Bentley-based veterinary medical technology company Chemeq Limited posted a half-year net loss of $13.6 million to December 31 2005, as it works its way through the commercialisation process for its technology.

Chemeq Ltd

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

18-Nov-05 Lodged response to ASX query

Chemeq’s $1.4m sales

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Veterinary pharmaceutical producer Chemeq has announced the signing of a sales order worth $1.4 million to the Perth-based company.

Fire at Chemeq facility

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

VETERINARY pharmaceutical company Chemeq has announced that it has sustained a small contained fire at its manufacturing facility in Rockingham, which it says was extinguished in minutes.

Chemeq’s new capital structure

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

LOCAL veterinary drug producer Chemeq has received notice from its investors Mizuho International, Stark Trading and Shepherd Investments, of their intention to secure their $40 million convertible bo

Chemeq locks in Chinese IP protection

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

EMERGING local veterinary pharmaceutical company Chemeq has secured patent protection for its polymeric antimicrobial product in China until the year 2020.